Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial

This phase I trial evaluated preoperative radiotherapy with concurrent capecitabine, bevacizumab and erlotinib for rectal cancer. Eighteen patients were evaluable. Treatment was well tolerated, and the maximum tolerated dose (MTD) was not reached. One patient had grade 3 acute toxicity and 3 patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Das, Prajnan, Eng, Cathy, Rodriguez-Bigas, Miguel A., Chang, George J., Skibber, John M., You, Y. Nancy, Maru, Dipen M., Munsell, Mark F., Clemons, Marilyn V, Kopetz, Scott E., Garrett, Christopher R., Shureiqi, Imad, Delclos, Marc E., Krishnan, Sunil, Crane, Christopher H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5592790/
https://ncbi.nlm.nih.gov/pubmed/24315563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.10.034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados